In Sudan, the production capacity for synthetic drugs has significantly increased, especially during the ongoing conflict, as highlighted by a major drug seizure in January 2026 where nearly half a tonne of drugs, primarily crystal meth, was confiscated in Red Sea State. This increase in drug production is indicative of Sudan's integration into a larger illicit economy, especially following the collapse of Syria's state-sponsored Captagon industry in December 2024. The disruption of this industry has led to a geographical shift, with synthetic drug production moving towards conflict zones characterized by weak governance and porous borders, making drug trafficking more prevalent.

The report from the Sudan Transparency and Policy Tracker (STPT) outlines how the collapse of Syria's Captagon production has opened avenues for illicit trade in regions like Sudan, where the foundations for such economies are already being established. This relocation of drug production is occurring against a backdrop of a growing global synthetic drug market, which has seen unprecedented levels of supply and demand. The growth of these illicit economies raises serious concerns about security and governance in affected areas, as they often lead to further entrenchment of criminal networks and instability.

As synthetic drug markets continue to thrive in Sudan, the implications for both local and regional stability are significant. The flourishing drug trade not only provides financial resources for armed groups but also complicates efforts for peace and governance in the country. As these dynamics evolve, addressing the challenges posed by drug production and trafficking will be crucial for restoring stability in Sudan and curbing the wider impacts of the global synthetic drug trade on conflict regions.